60
Pamphilon DH, Selogie E, Szczepiorkowski ZM; for the BEST Collaborative Cellular Therapies team.
Transportation of cellular therapy products: report of a survey by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) collaborative.
Vox Sang. 2010 Aug 1;99(2):168-73.
59
Lozano M, Heddle N, Williamson LM, Wang G, Aubuchon JP, Dumont LJ.
Practices associated with ABO-incompatible platelet transfusions: a BEST Collaborative international survey.
Transfusion 2010 August;50(8):1743-48.
58
Hess JR, Sparrow RL, van der Meer P, Acker JP, Cardigan RA, Devine DV for the BEST Collaborative.
Red cell hemolysis during blood bank storage: Using national quality management data to answer basic scientific questions.
Transfusion 2009 Dec;49(12):2599-603.
57
Nancy M Heddle, Richard J Cook, Alan Tinmouth, C. Tom Kouroukis, Tor Hervig, Ellen Klapper, Joseph M Brandwein, Zbigniew M Szczepiorkowski, James P AuBuchon, Rebecca L Barty, Ker-Ai Lee for the SToP Study Investigators of the BEST Collaborative.
A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) tto patients with thrombocytopenia.
Blood 2009, Feb;113:1564-1573.
56
Pieter F. van der Meer, Margriet J. Dijkstra-Tiekstra, Anne Mahon, and Janny deWildt-Eggen for the BEST Collaborative.
Counting platelets in platelet concentrates on hematology analyzers: a multicenter comparative study.
Transfusion 2009, Jan, 49:81-90.
55
JP AuBuchon, J de Wildt-Eggen, LJ Dumont.
Reducing the variation in the variation in performance of antibody titrations.
Vox Sanguinis 2008;95:57-65 and Arch Pathol Lab Med 2008;132:1194-1201. (joint publication).
54
Walter Sunny Dzik, Neil Beckman, Kathleen Selleng, Nancy Heddle, Zbigniew Szczepiorkowski, Silvano Wendel, and Michael Murphy for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Errors in patient specimen collection: application of statistical process control.
Transfusion 2008 Oct;48(10):2143-51.
53
LJ Dumont, JP AuBuchon for the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials.
Transfusion 2008;48:1053-60.
52
-
BACTERIAL CONTAMINATION (STUDY 34) NOT PUBLISHED
-
51
Brand A, Eichler H, Szczepiorkowski ZM, Hess JR, Kekomaki R, McKenna DH, Pamphilon D, Reems J, Sacher RA, Takahashi TA, van de Watering LM; Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise.
Transfusion. 2008 Mar;48(3):546-9.
